Redwood Pharma AB

Redwood Pharma is a pharmaceutical company. The main focus is on the production of ophthalmic pharmaceuticals. The products contain active substances that are used in the treatment of dry eye disease (DED), characterised by dryness, pain, and burning. The disorder is caused by inflammation due to dysfunction of the glands as well as by the usage of contact lenses. The company is based in Stockholm.

Quotes for Redwood Pharma AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Martin Vidaeus

Chairperson of the Board

  • Gunnar Mattsson

Board

  • Hans Ageland
  • Ingrid Atteryd-Heiman
  • Martin Vidaeus
  • Mats Lidgard
  • Articles of association

    • News

    Show More

    Analysis

    Videos

    Redwood Pharma - Om de lyckade resultaten för RP101 och vägen framåt

    Redwood Pharma announces the results from Phase 2 trials

    Redwood Pharma intervju på Biostock Live

    Redwood Pharma company presentation at BioStock Live

    Largest Owners

    Name Capital % Votes % Date
    Avanza Pension 4,87 4,87 2024-06-26
    Hampus Svensson 3,34 3,34 2024-06-26
    Joel Henriksson 2,27 2,27 2024-06-26
    Nathanael Thormalm 2,01 2,01 2024-06-26
    Bo Johan Peter Lundin 1,81 1,81 2024-06-26
    Anette Pålsson 1,74 1,74 2024-06-26
    Lennart Starby 1,61 1,61 2024-06-26
    Henrik Gustafsson 1,61 1,61 2024-06-26
    Jens Erik Bechmann 1,46 1,46 2024-06-26
    Sound & Vision Support I Sverige 1,41 1,41 2024-06-26

    Annual reports, prospectus etc.